Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

Debarati Bhanja; Junjia Zhu; Hannah Wilding; Jorge Benavides‐Vasquez; Leonardo de Macêdo Filho; Ahmad Ozair; Camille Moeckel; Aarav Badani; Jinpyo Hong; Jeffrey Sivik; Joseph J. Drabick; Colette R. Pameijer; Kim Margolin; Manmeet S. Ahluwalia; Alireza Mansouri

doi:10.1158/1078-0432.29760959

August 1, 2025

Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: There is a significant cumulative incidence of brain metastasis and death among melanoma patients after dual-agent immunotherapy.
KEY EVIDENCE: Data from three cohorts demonstrate the varying rates of brain metastases and mortality.
APPROACH: Analysis includes cumulative incidence functions to assess outcomes across different patient groups.
SIGNIFICANCE: Understanding these trends helps in better management and treatment strategies for melanoma patients.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Cumulative incidence functions of brain metastases and death in melanoma patients following immunotherapy, highlighting important epidemiological patterns.

Abstract

Supplemental Figure 2 shows the cumulative incidence functions of brain metastases and death in all three cohorts.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bhanja et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0145 https://doi.org/10.1158/1078-0432.29760959

View at Publisher

Ask AI

Bookmark

Share

Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Supplemental Figure 2 from A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading